Zhang Guofei, Liang Chengxiao, Shen Gang, Li Wenshan, Huang Lijian, Pan Saibo, Chai Ying
Department of Thoracic Surgery, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Department of Thoracic Surgery, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
J Thorac Cardiovasc Surg. 2014 Dec;148(6):2667-72. doi: 10.1016/j.jtcvs.2014.07.093. Epub 2014 Aug 6.
Sternal reconstruction after resection is essential for restoring the rigidity of the chest cavity. However, no consensus has been reached regarding the most physiologic or efficacious material for this procedure. We present our clinical experience with autogenous rib grafts for reconstruction of the manubrium after resection and discuss the refinements in this procedure.
Twelve consecutive patients with a confirmed diagnosis of a primary neoplasm in the manubrium between March 2003 and August 2013 were analyzed retrospectively. All patients underwent manubrium resection and immediate reconstruction with autogenous rib grafts.
No cases of perioperative mortality were noted. The median operation time was 129 minutes. One patient experienced mild paradoxical movement; the other patients recovered well without any complications. The median follow-up period after surgery was 69 months. Two patients died. One patient with chondrosarcoma died as a result of cardiac disease 26 months after surgery and another patient with non-Hodgkin lymphoma died as a result of local recurrence 6 months after surgery. Computed tomographic scans for the other 10 patients have shown neither dislocation nor abnormality of the transplanted ribs; moreover, no absorption of the grafts or recurrence was noted. None of the patients required prescription analgesics for the pain at the donor site at the 3-month follow-up visit.
This case series demonstrates the successful use of autogenous rib grafts in the reconstruction of the manubrium after resection. We consider that the reconstruction technique is a safe and effective alternative to a complex problem.
切除术后的胸骨重建对于恢复胸腔的刚性至关重要。然而,对于该手术最符合生理或最有效的材料尚未达成共识。我们介绍了使用自体肋骨移植重建切除后的胸骨柄的临床经验,并讨论了该手术的改进之处。
回顾性分析2003年3月至2013年8月期间连续12例确诊为胸骨原发性肿瘤的患者。所有患者均接受了胸骨柄切除并立即用自体肋骨移植进行重建。
未观察到围手术期死亡病例。中位手术时间为129分钟。1例患者出现轻度反常运动;其他患者恢复良好,无任何并发症。术后中位随访期为69个月。2例患者死亡。1例软骨肉瘤患者术后26个月因心脏病死亡,另1例非霍奇金淋巴瘤患者术后6个月因局部复发死亡。其他10例患者的计算机断层扫描显示移植肋骨无脱位或异常;此外,未观察到移植骨吸收或复发。在3个月的随访中,没有患者需要使用处方镇痛药来缓解供体部位的疼痛。
该病例系列证明了自体肋骨移植在切除术后胸骨柄重建中的成功应用。我们认为该重建技术是解决这一复杂问题的一种安全有效的替代方法。